Anaphylactic Reaction after Injection of Glatiramer Acetate (Copaxone®) in Patients with Relapsing-Remitting Multiple Sclerosis

Publisher： Karger

E-ISSN： 1421-9913|66|6|368-370

ISSN： 0014-3022

Source： European Neurology, Vol.66, Iss.6, 2011-11, pp. : 368-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait

By  

Medical Principles and Practice, Vol. 22, Iss. 5, 2013-06 ,pp. : 495-499

Karger

Access to resources Recommend Favorite

New Hypointense Lesions on MRI in Relapsing-Remitting Multiple Sclerosis Patients

By  

European Neurology, Vol. 43, Iss. 4, 2000-05 ,pp. : 194-200

Karger

Access to resources Recommend Favorite

Assessment of Driving Performance in Patients with Relapsing-Remitting Multiple Sclerosis by a Driving Simulator

By  

European Neurology, Vol. 50, Iss. 3, 2003-10 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Is Interferon Effective and Safe for Relapsing-Remitting Multiple Sclerosis?

By  

Neuroepidemiology, Vol. 21, Iss. 6, 2002-11 ,pp. : 310-

Karger

Access to resources Recommend Favorite

Switching to Second-Line Therapies in Interferon-Beta-Treated Relapsing-Remitting Multiple Sclerosis Patients

By  

European Neurology, Vol. 61, Iss. 3, 2009-01 ,pp. : 177-182

Karger

Access to resources Recommend Favorite